Lupus Therapeutics Shifting the Paradigm
The Lupus Research Alliance (LRA)—going bold and thinking big—has once again shifted the status quo of lupus research by...
Stories & News
Epilepsy in People with Lupus
October 17, 2019
A new study published in the European Journal of Neurology showed that epilepsy is significantly more common...
High Levels of Interferon-Alpha Identifies Lupus Patients At Risk for Relapse
October 7, 2019
A new study published in Annals of the Rheumatic Diseases found that among people with lupus, high...
Why Don’t Half of People with Lupus Take Hydroxychlorine As Prescribed?
October 3, 2019
Hydroxychlorine is one of the most common treatments for lupus. But a new study published in The...
2019 Breaking Through Gala
The Lupus Research Alliance celebrates our annual Breaking through Lupus Gala on November 25, 2019 at the Ziegfeld Ballroom...
LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch
October 1, 2019
The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...
Nearly One-third of People with Lupus Treat Their Pain with Opioids
September 26, 2019
In a newly published Michigan study, nearly 1 in 3 adults with systemic lupus erythematosus used prescription...
Hope Comes from Research!
September 25, 2019
Since being diagnosed with Systemic Lupus Erythematosus back in 2017, my world has turned upside down. The...
Accelerating Medicines Partnership Completes Key Phase
September 24, 2019
The Accelerating Medicines Partnership (AMP) RA/Lupus Program, a joint effort involving the National Institutes of Health (NIH),...
Low-Dose Interleukin-2 Might be Effective for Lupus
September 24, 2019
Interleukin-2 at a low-dose may be effective in treating lupus, according to newly published results of a...
Lupus Study Showed Vitamin D Did Not Improve Bone Health
September 19, 2019
A small clinical trial published in Lupus Science & Medicine found that taking vitamin D supplements did...
FDA Expedites Existing Drug Gazyva for Lupus Nephritis
September 18, 2019
The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...